Jessica Hopfield, Director at Editas Medicine, Inc. (EDIT), bought 10,200 shares at $23.94 ($244K) on 2019-03-05, disclosed to the SEC on 2019-03-07.
Open-market purchase of $244k EDIT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| EDIT | BUY | 2024-05-14 | $254K | — | Filing → |
| BLI | BUY | 2022-03-11 | $502K | — | Filing → |
| EDIT | BUY | 2021-03-05 | $264K | — | Filing → |